Oligonucleotide compositions and methods thereof
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- WAVE LIFE SCI LTD
- Filing Date
- 2025-10-29
- Publication Date
- 2026-06-11
AI Technical Summary
Existing oligonucleotide technologies face challenges in efficiently editing nucleic acids, particularly in converting adenosine to inosine, with issues related to stability, selectivity, cellular uptake, immune stimulation, and toxicity, especially when utilizing exogenous components.
Designing oligonucleotides with specific sugar modifications, nucleobase modifications, and internucleotidic linkages, such as 2'-F and 2'-OR modifications, along with chirally controlled internucleotidic linkages, to enhance editing efficiency and selectivity, stability, and reduce immune stimulation and toxicity.
The designed oligonucleotides demonstrate improved stability, selectivity, and reduced toxicity, enabling efficient adenosine-to-inosine conversion in nucleic acids, particularly in mRNA, utilizing endogenous ADAR proteins for targeted editing.
Smart Images

Figure US2025053202_11062026_PF_FP_ABST